Johnson & Johnson has announced that it will increase its presence in North Carolina with a 160,000+ square foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. The $2 billion commitment to Fujifilm over the next 10 years will expand the company’s US manufacturing capacity and create approximately 120 new jobs in North Carolina, US.
In the coming months, the company also intends to share the plans for additional advanced manufacturing facilities in the US as well as the expansion of current US sites. These plans reinforce Johnson & Johnson’s leadership in delivering cutting-edge healthcare solutions and will enable the company to manufacture the vast majority of advanced medicines in the US to meet the needs of the patients.
In March, the company announced that it will invest $55 billion to support US manufacturing, research and development, and technology investments over the next four years.
